| Literature DB >> 27642375 |
Esther I de Bruin1, J Esi van der Zwan2, Susan M Bögels1,3.
Abstract
Our Western society is characterized by multitasking, competition, and constant time pressure. Negative effects of stress for the individual (anxiety, depression, somatic complaints) and for organizations and society (costs due to work absence) are very high. Thus, time-efficient self-help interventions to address these issues are necessary. This study assessed the effects of daily mindfulness meditations (MM) versus daily heart rate variability biofeedback (HRV-BF) and daily physical exercise (PE) on attention control, executive functioning, mindful awareness, self-compassion, and worrying. Young adults (n = 75, age range 18 to 40) with elevated stress levels were randomized to MM, HRV-BF, or PE, and measurements were taken at pre-test, post-test, and follow-up. Interventions in all three groups were self-guided and lasted for 5 weeks. Generalized estimating equation analyses showed that overall, all three interventions were effective and did not differ from each other. However, practice time differed between groups, with participants in the PE group practicing much more than participants in the other two groups. Therefore, additional analyses were carried out in two subsamples. The optimal dose sample included only those participants who practiced for at least 70 % of the total prescribed time. In the equal dose sample, home practice intensity was equal for all three groups. Again, the effects of the three interventions did not differ. In conclusion, MM, HRV-BF, and PE are all effective self-help methods to improve attention control, executive functioning, mindful awareness, self-compassion, and worrying, and mindfulness meditation was not found to be more effective than HRV-biofeedback or physical exercise for these cognitive processes.Entities:
Keywords: Attention control; Executive functioning; HRV-biofeedback; Mindful awareness; Mindfulness meditation; Physical exercise; Self-compassion; Worrying
Year: 2016 PMID: 27642375 PMCID: PMC5010624 DOI: 10.1007/s12671-016-0561-5
Source DB: PubMed Journal: Mindfulness (N Y) ISSN: 1868-8527
Fig. 1Consolidated Standards of Reporting Trial (CONSORT) diagram for a RCT of mindfulness meditation, heart rate variability biofeedback, and physical exercise. Adapted with permission from “Physical activity, mindfulness meditation, or heart rate variability biofeedback for stress reduction: a randomized controlled trial” by Van der Zwan et al. (2015), Applied Psychophysiology and Biofeedback. Copyright 2015 by the authors
Means (SDs) and within-group effect sizes of change in the mindfulness meditation, heart rate variability biofeedback, and physical exercise groups for attention control, executive functioning, mindful awareness, self-compassion, and worrying, at pre-test, post-test, and follow-up, in the total sample, the optimal dose sample, and the equal dose sample
| Total sample | Optimal dose sample | Equal dose sample | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| ||
| ACS | MM | 50.11 (9.43) | 51.76 (8.33) | 53.75 (7.85) | 0.13 | 0.47 | 0.34 | 0.95 | 0.34 | 0.88 |
| HRV-BF | 52.72 (7.84) | 53.67 (8.88) | 52.48 (8.17) | 0.16 | 0.01 | 0.28 | 0.33 | 0.24 | 0.02 | |
| PE | 52.22 (9.66) | 55.09 (8.18) | 54.90 (8.68) | 0.39 | 0.52 | 0.25 | 0.38 | 0.45 | 0.64 | |
| BRIEF-A | MM | 127.89 (25.30) | 123.76 (22.42) | 118.20 (24.47) | 0.14 | 0.68 | 0.19 | 0.73 | 0.36 | 0.88 |
| HRV-BF | 119.52 (15.88) | 121.58 (17.15) | 119.57 (17.15) | 0.19 | 0.02 | 0.17 | 0.29 | 0.03 | 0.06 | |
| PE | 122.35 (19.49) | 120.23 (25.10) | 119.05 (28.46) | 0.10 | 0.25 | 0.07 | 0.46 | 0.24 | 0.34 | |
| FFMQ | MM | 77.85 (9.81) | 80.80 (7.82) | 81.17 (9.95) | 0.27 | 0.35 | 0.61 | 0.89 | 0.48 | 0.52 |
| HRV-BF | 77.28 (11.09) | 83.67 (8.89) | 83.30 (8.44) | 0.68 | 0.58 | 0.88 | 1.22 | 0.81 | 0.78 | |
| PE | 74.57 (10.50) | 82.82 (10.17) | 80.35 (10.48) | 0.99 | 0.61 | 1.02 | 0.62 | 1.24 | 0.79 | |
| SCS | MM | 3.90 (1.13) | 4.32 (0.98) | 4.31 (1.10) | 0.39 | 0.39 | 0.50 | 0.62 | 0.44 | 0.49 |
| HRV-BF | 4.07 (1.08) | 4.35 (1.12) | 4.21 (1.10) | 0.44 | 0.16 | 0.45 | 0.12 | 0.53 | 0.14 | |
| PE | 3.76 (0.76) | 4.21 (0.87) | 4.12 (0.99) | 0.78 | 0.36 | 0.68 | 0.73 | 0.72 | 0.58 | |
| PSWQ | MM | 56.78 (13.87) | 53.12 (13.42) | 53.08 (15.89) | 0.46 | 0.51 | 0.46 | 0.62 | 0.46 | 0.59 |
| HRV-BF | 51.40 (14.32) | 48.42 (14.28) | 48.70 (14.31) | 0.36 | 0.32 | 0.77 | 0.99 | 0.58 | 0.56 | |
| PE | 53.91 (13.56) | 49.73 (14.65) | 50.35 (14.37) | 0.69 | 0.47 | 0.84 | 0.47 | 0.56 | 0.51 | |
ACS Attention Control Scale, BRIEF-A Behavior Rating Inventory of Executive Function–Adult version, ES effect size, FFMQ Five Facet Mindfulness Questionnaire, FU follow-up, HRV-BF heart rate variability biofeedback, MM mindfulness meditation, PE physical exercise, PSWQ Penn State Worry Questionnaire, SCS Self-Compassion Scale
Optimal dose: participants with >70% of the prescribed exercise time
Fig. 2a Attention Control Scale (ACS) b Behavior Rating Inventory of Executive Function–Adult version (BRIEF-A) c Five Facet Mindfulness Questionnaire (FFMQ) d Self-Compassion Scale (SCS) and e Penn State Worry Questionnaire (PSWQ) at pre-test (T1), post-test (T2), and follow-up (T3) for the equal dose group mindfulness meditation, HRV-biofeedback, and physical exercise